Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. With atrial fibrillation, part of the ...

See "Use of Non-GAAP Financial Information". All comparisons are made versus the same period in 2023 unless otherwise stated. Bristol Myers Squibb posted third quarter revenues of $11.9 billion, an ...

A look at Kamala Harris and Donald Trump's stances on health care and what they've said about health care policy going into ...

Metoprolol can interact with several types of medications, including certain blood pressure drugs, monoamine oxidase ...

and apixaban (brand name Eliquis) used to prevent blood clots and stroke in people with atrial fibrillation. They were ...

The anticlotting drug, Eliquis, has been approved for use in the United States by the country’s regulatory body, the Food and Drug Administration (FDA). Eliquis is manufactured by Bristol-Myers ...

Eliquis: Jardiance Xarelto These negotiated drug prices will go into effect for Medicare Part D recipients on Jan. 1, 2026.

We think Pfizer’s top line will see growth in the low teens, driven by market share gains for Vyndaqel and Abrysvo.

Those drugs were Eliquis, Jardiance ... Approximately 10 million Medicare enrollees used this set of 10 drugs in 2023 (combined), so it's expected the lower prices will have a wide impact.

The biggest pharmacy benefit managers are profiting by systematically underpaying independent drugstores, creating “pharmacy ...

Lawyers for AstraZeneca , Bristol Myers Squibb and Johnson & Johnson's Janssen on Wednesday urged a federal appeals court in ...